Stallergenes Greer

Description: Global biopharma firm specializing in allergy immunotherapy, with 1,100+ employees across 40 countries, enabling precision medicine for respiratory allergies.

Country: UK

Based in: London

Founded: 2015

Funding Stage: Series C & Beyond

Tags: ['Stallergenes Greer']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.